21.2 C
New York
Saturday, June 15, 2024
HomeMarkets
Markets

Leerink Swann Initiates Pacira Pharmaceuticals With Market Perform

By Insider Scoop
0
10
psw-placeholder
psw-placeholder

Courtesy of Benzinga.

Related PCRX
Benzinga's Top Initiations
Who's The Next Big Pharma Acquisition?

Analysts at Leerink Swann initiated coverage on Pacira Pharmaceuticals Inc (NASDAQ: PCRX) with a Market Perform rating.

The target price for Pacira Pharmaceuticals is set to $86.

Pacira Pharmaceuticals shares have dropped 11.28 percent over the past 52 weeks, while the S&P 500 index has surged 8.07 percent in the same period.

Pacira Pharmaceuticals’ shares rose 1.35 percent to close at $78.18 yesterday.

Latest Ratings for PCRX

Date Firm Action From To
Jun 2015 Leerink Swann Initiates Coverage on Market Perform
May 2015 Canaccord Genuity Maintains Buy
Mar 2015 Barclays Maintains Overweight

View More Analyst Ratings for PCRX
View the Latest Analyst Ratings

Posted-In: Leerink SwannInitiation Analyst Ratings

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,091FansLike
396,312FollowersFollow
2,300SubscribersSubscribe

Latest Articles

Load more

Note: The material presented in this commentary is provided for informational purposes only and is based upon information that is considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW) nor its affiliates warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.

This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

Contact us: support@philstockworld.com

© Copyright - PSW, LLC.

2024
0
Would love your thoughts, please comment.x
()
x